AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

about

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Item

http://www.wikidata.org/entity/Q61921358

description

clinical trial

@en

klinisch onderzoek

@nl

name

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

@en

type

Item

label

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

@en

prefLabel

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

@en

P1476

A Phase II Clinical and Biolog ...... ow-Grade Neuroendocrine Tumors

@en

P17

Ameeriga Ütisriigiq

P2899

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT00427349

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4844

niacinamide

Octreotide

P580

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P6153

Case Western Reserve University

Hurley Medical Center

Metro-Minnesota Community Oncology Research Consortium

Michigan Cancer Research Consortium

Iowa Methodist Medical Center

Park Nicollet Methodist Hospital

West Michigan Cancer Center

University of Pennsylvania

Akron City Hospital heliport

Creighton University

P8005

completed

P859

Eastern Cooperative Oncology Group

P921

intestinal neuroendocrine benign tumor

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

about

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

description

name

type

label

prefLabel

P1132

P1476

P17

P2899

P3098

P31

P4844

P580

P582

P6099

P6153

P8005

P859

P921

P1132

P1476

P17

P2899

P3098

P31

P4844

P580

P582

P6099

P6153

P8005

P859

P921